The Effectiveness of Paracetamol in Postoperative Pain Relief
Postoperative pain management is a critical aspect of patient care, with significant implications for recovery, rehabilitation, and overall quality of life. Among the various analgesic options available, paracetamol (also known as acetaminophen) has emerged as a promising non-opioid alternative, offering several advantages over traditional nonsteroidal anti-inflammatory drugs (NSAIDs).
Recent studies have explored the efficacy of intravenous (IV) paracetamol in managing postoperative pain and swelling following major oral and maxillofacial surgeries. These findings provide valuable insights into the comparative performance of paracetamol and the commonly used NSAID, diclofenac sodium.
Paracetamol vs. Diclofenac Sodium: A Comparative Analysis
A double-blind, randomized, prospective study compared the effectiveness of IV paracetamol (1 gram) and IV diclofenac sodium (75 mg) in managing postoperative pain and edema in 140 patients undergoing similar major oral and maxillofacial surgical procedures. The study utilized various assessment tools, including the Visual Analogue Scale (VAS), Verbal Response Scale (VRS), and a thread method for measuring swelling.
The results of this comparative analysis revealed several key findings:
-
Longer Pain-free Interval: Patients treated with IV paracetamol experienced a significantly longer pain-free interval compared to those receiving diclofenac sodium. According to VAS and VRS assessments, patients on paracetamol were completely pain-free for almost 5 hours, compared to only 3 hours for those on diclofenac sodium.
-
Reduced Dose Requirements: The number of doses required to achieve adequate pain relief was lower in the paracetamol group, with 29 and 14 patients in the 2-hour and 3-4-hour surgery groups, respectively, requiring only a single dose, compared to 7 and 3 patients in the diclofenac sodium group.
-
Faster Swelling Resolution: The duration required for swelling resolution was shorter in the paracetamol group, with patients achieving adequate mouth opening in cases of space infections in an average of 4.4 days, compared to 5.9 days in the diclofenac sodium group.
These findings suggest that IV paracetamol is a superior analgesic to diclofenac sodium in relieving postoperative pain and swelling in major oral and maxillofacial surgeries. Patients treated with paracetamol experienced a longer pain-free interval, required fewer doses, and exhibited faster resolution of swelling.
Paracetamol: A Versatile Non-Opioid Analgesic
The advantages of paracetamol over other pain management options have been well-documented in various medical fields. Numerous studies have explored the efficacy of paracetamol in providing postoperative pain relief, with variable results in terms of the duration and onset of analgesia.
Onset and Duration of Analgesia
One systematic review found that the use of paracetamol at standard doses reduced at least 50% of pain over 4-6 hours following a single dose. Another study reported that a combination of 1 gram of paracetamol and 40 mg of parecoxib showed positive changes in the VAS score at rest and during movement at an 8-hour interval.
However, not all studies have demonstrated a clear superiority of paracetamol over other analgesic options. A review article reported that the overall mean index measurement of pain in the period from 30 minutes to 4 hours after surgery showed an insignificant difference between acetaminophen and diclofenac.
Opioid-Sparing Effects
Despite these mixed findings, many studies have reported a reduction in opioid consumption when paracetamol is used as part of a multimodal analgesia approach. A review article found that the use of paracetamol reduced the need for rescue doses of opioids over a 24-hour study interval, with the median time to first rescue medication being 4 hours for IV acetaminophen and 1.6 hours for the placebo group.
Similarly, a combination of paracetamol and parecoxib has been shown to reduce the number of morphine doses required in the postoperative period. Propacetamol (a prodrug of acetaminophen) or IV paracetamol has also been found to reduce the amount of morphine consumption in 16-46% of patients undergoing various surgical procedures, including orthopedic, spinal, and tonsillectomy surgeries.
Paracetamol in Oral and Maxillofacial Surgeries
While numerous studies have been conducted in other medical fields, the evidence on the efficacy of paracetamol in major oral and maxillofacial procedures is relatively limited. A few studies have compared paracetamol to other analgesic options in the context of these specialized surgeries.
Paracetamol vs. Other NSAIDs
A study comparing the postoperative pain relief provided by IV paracetamol (1 gram) and intramuscular diclofenac sodium (75 mg) in bimaxillary osteotomies found that both drugs were comparable in effectively decreasing pain within the first 12 hours after surgery.
In minor oral surgeries, such as primary tooth extractions and cavity preparations, paracetamol has been compared to other NSAIDs, such as ibuprofen and diclofenac potassium. These studies have yielded mixed results, with ibuprofen and diclofenac potassium demonstrating better analgesic efficacy compared to paracetamol in some cases.
Paracetamol vs. Ketorolac and Celecoxib
A study comparing paracetamol (500 mg) and ketorolac (10 mg) concluded that the requirement for rescue analgesia was needed earlier in the paracetamol group (after 5 hours) compared to the ketorolac group (after 4 hours).
Another study compared paracetamol (1000 mg), celecoxib (400 mg), and diclofenac sodium (50 mg) in patients undergoing impacted third molar surgeries and removal of plates and screws. The duration of postoperative analgesia was found to be 3-4 hours for all the drugs.
The Safety Profile of Paracetamol
In addition to its analgesic efficacy, paracetamol has also demonstrated a favorable safety profile compared to other analgesic options, particularly NSAIDs. Studies have reported a lower incidence of adverse events, such as nausea and vomiting, with the use of paracetamol compared to opioids and NSAIDs.
A systematic review found that the incidence of nausea and vomiting was significantly lower in patients receiving IV acetaminophen compared to those receiving placebo or IV opioids. There was no significant difference in the incidence of these adverse events when IV acetaminophen was compared to IV NSAIDs.
Furthermore, the review did not find any significant difference in the overall incidence of adverse events between IV acetaminophen and placebo. This suggests that paracetamol is a well-tolerated analgesic option, with a lower risk of opioid-related side effects, making it a valuable component of multimodal pain management strategies.
Conclusion
The available evidence suggests that IV paracetamol is a superior non-opioid analgesic compared to IV diclofenac sodium in managing postoperative pain and swelling following major oral and maxillofacial surgeries. Patients treated with paracetamol experienced a longer pain-free interval, required fewer doses, and exhibited faster resolution of swelling.
The versatility of paracetamol as an analgesic has been demonstrated in various medical fields, with studies reporting its opioid-sparing effects and favorable safety profile. While the evidence on the use of paracetamol in major oral and maxillofacial procedures is limited, the findings from this comparative study and the broader literature highlight the potential of paracetamol as a valuable component of multimodal pain management strategies in the postoperative setting.
As healthcare professionals continue to prioritize patient-centered care and optimize postoperative recovery, the judicious use of paracetamol, either alone or in combination with other analgesic options, may contribute to enhanced pain relief, reduced opioid consumption, and improved overall patient outcomes.
References
-
Girotra, C., Padhye, M., Mahajan, P., Savla, S., Nair, A., Pardeshi, P., Tomar, G., & Kini, Y. (2023). Paracetamol is an optimal non-opioid analgesic and holds considerable advantages over NSAIDs in managing post-operative pain. Journal of Maxillofacial & Oral Surgery, 22(1), 1-10. https://pmc.ncbi.nlm.nih.gov/articles/PMC9871110/
-
Al-Khateeb, T. H., & Nusair, Y. (2001). Effect of intravenous administration of paracetamol on postoperative pain after adenotonsillectomy in children. International Journal of Oral and Maxillofacial Surgery, 31(6), 642-646. https://pubmed.ncbi.nlm.nih.gov/11299404/
-
Doleman, B., Leonardi-Bee, J., Heinink, T. P., Bhattacharjee, D., Lund, J. N., & Williams, J. P. (2018). A systematic review and meta-analysis of the role of nonsteroidal anti-inflammatory drugs in post-operative pain management. Anaesthesia, 73(6), 721-731. https://www.bjanaesthesia.org/article/S0007-0912(17)36531-5/fulltext
-
Sharada, H., & Frey, N. (2018). Intravenous Acetaminophen for the Management of Short-Term Post-Operative Pain: A Review of Clinical Effectiveness and Cost-Effectiveness. CADTH Rapid Response Report: Summary with Critical Appraisal. https://www.ncbi.nlm.nih.gov/books/NBK538274/
